Skip to content

Reducing Adult Inpatients Anxiety With Virtual Reality Meditation

Reducing Adult Inpatients Anxiety With Virtual Reality Meditation: A Prospective, Randomized Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06234254
Enrollment
200
Registered
2024-01-31
Start date
2026-06-01
Completion date
2027-05-31
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Virtual Reality

Brief summary

The purpose of the study is to evaluate if non-invasive, distracting devices (virtual reality) can decrease anxiety and improve affect and satisfaction in adult, hospitalized patients.

Interventions

Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* between age 18-99 * hospitalized at Stanford Health Care * english-speaking

Exclusion criteria

* significant cognitive impairment or inability to consent * current nausea * visual problems or currently using corrective glasses that are incompatible with the virtual reality headset * a history of severe motion sickness * a history of seizures cause by flashing light * clinically unstable or require immediate/urgent intervention

Design outcomes

Primary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale (HADS)Before and Immediate after interventionHospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.

Countries

United States

Contacts

Primary ContactThomas Caruso
tjcaruso@stanford.edu650-723-5728
Backup ContactMan Yee Suen
msuen@stanfordchildrens.org650-723-5728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026